BioSpace News Archive

Bio NC

Congruence Therapeutics to Present at Multiple Investor Conferences in May 2023

Congruence Therapeutics, a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding, announced that management will participate in the following investor conferences.

May 4, 2023
·
1 min read
Business

Artivion Reports First Quarter 2023 Financial Results

Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced its financial results for the first quarter ended March 31, 2023.

May 4, 2023
·
16 min read
Business

Biolase to Report First Quarter 2023 Results on May 11, 2023

BIOLASE, Inc. announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.

May 4, 2023
·
2 min read
Pharm Country

Trevi Therapeutics to Report Q1 2023 Financial Results and Provide a Corporate Update on May 11, 2023

Trevi Therapeutics, Inc. announced that senior management will host a conference call and live audio webcast on Thursday, May 11, 2023, at 4:30 p.m. ET, to provide a corporate update and review the Company’s financial results for the first quarter ended March 31, 2023.

May 4, 2023
·
2 min read
Business

Insulet Reports First Quarter 2023 Revenue Increase of 21% Year-Over-Year (23% Constant Currency1)

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced financial results for the three months ended March 31, 2023.

May 4, 2023
·
13 min read
Business

Rocket Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Progress

Rocket Pharmaceuticals, Inc. reported financial results for the quarter ending March 31, 2023, and updates from the Company’s key pipeline developments, business operations and upcoming milestones.

May 4, 2023
·
14 min read
Business

Collegium Reports First Quarter 2023 Financial Results

Collegium Pharmaceutical, Inc., a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, reported its financial results for the quarter ended March 31, 2023, and provided a corporate update.

May 4, 2023
·
17 min read
Business

NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

NeuroPace, Inc., a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, reported financial results for the first quarter ended March 31, 2023.

May 4, 2023
·
8 min read
Business

Spectral Medical Inc. Announces Director Resignation

Spectral Medical Inc., a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, announced that Mr. Jim Funk has tendered his resignation from the Board of Directors of the Company, such resignation to take effect immediately.

May 4, 2023
·
2 min read
Business

Celldex Reports First Quarter 2023 Financial Results and Provides Corporate Update

Celldex Therapeutics, Inc. reported financial results for the first quarter ended March 31, 2023 and provided a corporate update.

May 4, 2023
·
12 min read